Genomica of Boulder, Colo., has appointed Michael Savage to its board of directors. Savage was CEO of Molecular Simulations from 1991 until the company was acquired by Pharmacopeia in 1998 and is currently principal of Savage Consulting.
Savage will fill the board seat being vacated by Arnold Levine, president of Rockefeller University and a scientific trustee of Cold Spring Harbor Laboratory, who is joining the company’s scientific advisory board.
Gregory Abbott and Jon Saxe have been appointed to the board of directors of diaDexus of Santa Clara, Calif.
Abbott is the managing partner of the Seattle office of law firm Cooley Godward and previously served as CEO at Synergen, acquired by Amgen; Darwin Molecular, acquired by Chiroscience; and AlphaGene.
Saxe currently sits on the boards of several companies and served as president of Protein Design Labs and Saxe Associates and president and CEO of Synergen. Saxe takes the place of Randy Scott, who stepped down to focus on his new company, Genomic Health.